In Vitro Cross-Resistance Profiles of Rilpivirine, Dapivirine, and MIV-150, Nonnucleoside Reverse Transcriptase Inhibitor Microbicides in Clinical Development for the Prevention of HIV-1 Infection.
about
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa.Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-]pyrimidine non-nucleoside inhibitors
P2860
In Vitro Cross-Resistance Profiles of Rilpivirine, Dapivirine, and MIV-150, Nonnucleoside Reverse Transcriptase Inhibitor Microbicides in Clinical Development for the Prevention of HIV-1 Infection.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
In Vitro Cross-Resistance Prof ...... Prevention of HIV-1 Infection.
@en
type
label
In Vitro Cross-Resistance Prof ...... Prevention of HIV-1 Infection.
@en
prefLabel
In Vitro Cross-Resistance Prof ...... Prevention of HIV-1 Infection.
@en
P2860
P356
P1476
In Vitro Cross-Resistance Prof ...... Prevention of HIV-1 Infection.
@en
P2093
Nicholas S Giacobbi
Nicolas Sluis-Cremer
P2860
P356
10.1128/AAC.00277-17
P407
P577
2017-05-15T00:00:00Z